Mejia-Zambrano, H. (2022). SGLT-2 inhibitors in patients with heart failure and reduced ejection fraction with or without diabetes.
Citación estilo ChicagoMejia-Zambrano, Henry. SGLT-2 Inhibitors in Patients With Heart Failure and Reduced Ejection Fraction With or Without Diabetes. 2022.
Cita MLAMejia-Zambrano, Henry. SGLT-2 Inhibitors in Patients With Heart Failure and Reduced Ejection Fraction With or Without Diabetes. 2022.
Precaución: Estas citas no son 100% exactas.